Targeting ER stress–induced autophagy overcomes BRAF inhibitor resistance in melanoma
Open accessThe DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
Melanomas that result from mutations in the gene encoding BRAF often become resistant to BRAF inhibition (BRAFi), with multiple mechanisms contributing to resistance. While therapy-induced autophagy promotes resistance to a number of therapies, especially those that target PI3K/mTOR signaling, its role as an adaptive resistance mechanism to BRAFi is not well characterized. Using tumor biopsies from BRAF(V600E) melanoma patients treated either with BRAFi or with combined BRAF and MEK inhibition, we found that BRAFi-resistant tumors had increased levels of autophagy compared with baseline. Patients with higher levels of therapy-induced autophagy had drastically lower response rates to BRAFi and a shorter duration of progression-free survival. In BRAF(V600E) melanoma cell lines, BRAFi or BRAF/MEK inhibition induced cytoprotective autophagy, and autophagy inhibition enhanced BRAFi-induced cell death. Shortly after BRAF inhibitor treatment in melanoma cell lines, mutant BRAF bound the ER stress gatekeeper GRP78, which rapidly expanded the ER. Disassociation of GRP78 from the PKR-like ER-kinase (PERK) promoted a PERK-dependent ER stress response that subsequently activated cytoprotective autophagy. Combined BRAF and autophagy inhibition promoted tumor regression in BRAFi-resistant xenografts. These data identify a molecular pathway for drug resistance connecting BRAFi, the ER stress response, and autophagy and provide a rationale for combination approaches targeting this resistance pathway.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Inhibition of BRAFV600E with vemurafenib induces autophagy by inhibition of the mTOR signaling pathway, and autophagy has been shown to promote survival of melanoma cells after vemurafenib81,85.”
From Mechanisms and prevention of UV‐induced melanoma (2018) · cites this paper as [81]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Induction of autophagy has been suggested to be a pro-survival mechanism for melanoma cells79,81,82.”
From Mechanisms and prevention of UV‐induced melanoma (2018) · cites this paper as [81]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Improved survival with vemurafenib in melanoma with BRAF V600E mutation
Chapman, P. B., Hauschild, A., Robert, C., Haanen, J. B., Ascierto, P., Larkin, J., Dummer, R., Garbe, C., Testori, A., Maio, M., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1103782 · Cited by 7,720
The Unfolded Protein Response: From Stress Pathway to Homeostatic Regulation
Walter, P., & Ron, D. (2011) · Science · doi:10.1126/science.1209038 · Cited by 5,924
Guidelines for the use and interpretation of assays for monitoring autophagy
Klionsky, D. J., Abdalla, F. C., Abeliovich, H., Abraham, R. T., Acevedo-Arozena, A., Adeli, K., Agholme, L., Agnello, M., Agostinis, P., Aguirre-Ghiso, J. A., et al. (2012) · Autophagy · doi:10.4161/auto.19496 · Cited by 4,330 · cited 7×
“LC3 is an ubiquitin-like cytoplasmic protein that is conjugated to the surface of AVs as they are formed.”
InfluentialSelf-citationClonogenic assay of cells in vitro
Franken, N. A. P., Rodermond, H. M., Stap, J., Haveman, J., & van Bree, C. (2006) · Nature Protocols · doi:10.1038/nprot.2006.339 · Cited by 4,188
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
Flaherty, K. T., Puzanov, I., Kim, K. B., Ribas, A., McArthur, G. A., Sosman, J. A., O'Dwyer, P. J., Lee, R. J., Grippo, J. F., Nolop, K., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002011 · Cited by 3,103
Hauschild, A., Grob, J.-J., Demidov, L. V., Jouary, T., Gutzmer, R., Millward, M., Rutkowski, P., Blank, C. U., Miller, W. H., Kaempgen, E., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60868-x · Cited by 2,989
Dynamic interaction of BiP and ER stress transducers in the unfolded-protein response
Bertolotti, A., Zhang, Y., Hendershot, L. M., Harding, H. P., & Ron, D. (2000) · Nature Cell Biology · doi:10.1038/35014014 · Cited by 2,860
Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations
Flaherty, K. T., Infante, J. R., Daud, A., Gonzalez, R., Kefford, R. F., Sosman, J., Hamid, O., Schuchter, L., Cebon, J., Ibrahim, N., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1210093 · Cited by 2,810
Self-citationPhosphorylation of ULK1 (hATG1) by AMP-Activated Protein Kinase Connects Energy Sensing to Mitophagy
Egan, D. F., Shackelford, D. B., Mihaylova, M. M., Gelino, S., Kohnz, R. A., Mair, W., Vasquez, D. S., Joshi, A., Gwinn, D. M., Taylor, R., et al. (2011) · Science · doi:10.1126/science.1196371 · Cited by 2,600
Direct observation of individual endogenous protein complexes in situ by proximity ligation
Söderberg, O., Gullberg, M., Jarvius, M., Ridderstråle, K., Leuchowius, K.-J., Jarvius, J., Wester, K., Hydbring, P., Bahram, F., Larsson, L.-G., et al. (2006) · Nature Methods · doi:10.1038/nmeth947 · Cited by 2,419 · cited 9×
“PLA was performed using Duolink In Situ fluorescence technology (Olink Bioscience).”
Influential
Cited by
Items 201–300 of 490
Huang, Y., Feng, Y., Wang, Y., Wang, P., Wang, F., & Ren, H. J. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00441 · Cited by 33
Kim, H.-J., Lee, S. Y., Kim, C. Y., Kim, Y. H., Ju, W., & Kim, S. C. (2016) · Oncotarget · doi:10.18632/oncotarget.14245 · Cited by 33
Dimeric quinacrines as chemical tools to identify PPT1, a new regulator of autophagy in cancer cells
Nicastri, M. C., Rebecca, V. W., Amaravadi, R. K., & Winkler, J. D. (2017) · Molecular & Cellular Oncology · doi:10.1080/23723556.2017.1395504 · Cited by 33
Self-citationVerykiou, S., Alexander, M., Edwards, N., Plummer, R., Chaudhry, B., Lovat, P. E., & Hill, D. S. (2018) · British Journal of Dermatology · doi:10.1111/bjd.17333 · Cited by 34
Nongenetic Mechanisms of Drug Resistance in Melanoma
Rebecca, V. W., & Herlyn, M. (2019) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030419-033533 · Cited by 32
Self-citationOvercoming Resistance to Therapies Targeting the MAPK Pathway in BRAF-Mutated Tumours
Paton, E. L., Turner, J. A., & Schlaepfer, I. R. (2020) · Journal of Oncology · doi:10.1155/2020/1079827 · Cited by 32
Emerging dimensions of autophagy in melanoma
Pangilinan, C. R., Klionsky, D. J., & Liang, C. (2024) · Autophagy · doi:10.1080/15548627.2024.2330261 · Cited by 32
Sui, L., Zhang, R., Zhang, P., Yun, K., Zhang, H., Liu, L., & Hu, M.-X. (2015) · Bioscience Reports · doi:10.1042/bsr20140164 · Cited by 32
The renewed battle against RAS-mutant cancers
Zhang, F., & Cheong, J. K. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2155-8 · Cited by 32
Nagasawa, I., Kunimasa, K., Tsukahara, S., & Tomida, A. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.12.062 · Cited by 33
Huang, W., Liang, Y., & Ma, X. (2019) · Cancer Cell International · doi:10.1186/s12935-019-0869-z · Cited by 32
Self-citationT-Type Calcium Channels as Potential Therapeutic Targets in Vemurafenib-Resistant BRAFV600E Melanoma
Barceló, C., Sisó, P., Maiques, Ó., García‐Mulero, S., Pamplona, R. S., Navaridas, R., Megino‐Luque, C., Felip, I., Urdanibia, I., Eritja, N., et al. (2019) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2019.11.014 · Cited by 32
Nti, A. A., Serrano, L. W., Sandhu, H. S., Uyhazi, K. E., Edelstein, I. D., Zhou, E. J., Bowman, S., Song, D., Gangadhar, T. C., Schuchter, L. M., et al. (2019) · Retina · doi:10.1097/iae.0000000000002027 · Cited by 31
Self-citationLiu, Z., Liu, J., Li, L., Nie, D., Tao, Q., Wu, J., Fan, J., Lin, C., Zhao, S., & Ju, D. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135236 · Cited by 31
Monitoring autophagy in cancer: From bench to bedside
Long, M., & McWilliams, T. G. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.05.016 · Cited by 30
Skin Photodamage and Melanomagenesis: A Comprehensive Review
Manganelli, M., Stabile, G., Scharf, C., Brunetti, A. P., Paolino, G., Giuffrida, R., Bigotto, G. D., Damiano, G., Mercuri, S. R., Sallustio, F., et al. (2025) · Cancers · doi:10.3390/cancers17111784 · Cited by 30
Autophagy in Cancer Therapy—Molecular Mechanisms and Current Clinical Advances
Ganzleben, I., Neurath, M. F., & Becker, C. (2021) · Cancers · doi:10.3390/cancers13215575 · Cited by 30
Degradation of AMPK‐α1 sensitizes BRAF inhibitor‐resistant melanoma cells to arginine deprivation
Li, Y., Wu, C., Shah, S. S., Chen, S., Wangpaichitr, M., Kuo, M. T., Feun, L. G., Han, X., Suarez, M., Prince, J. S., et al. (2017) · Molecular Oncology · doi:10.1002/1878-0261.12151 · Cited by 29
Emerging targets for combination therapy in melanomas
Saito, R. D. F., Tortelli, T. C., Jacomassi, M. D., Otake, A. H., & Chammas, R. J. (2015) · FEBS Letters · doi:10.1016/j.febslet.2015.09.022 · Cited by 28
Drug Repurposing to Target the Apoptosome in MAPKi-Resistant Melanoma
Carotenuto, P., Romano, A., Barbato, A., Quadrano, P., Brillante, S., Volpe, M., Ferrante, L., Tammaro, R., Morleo, M., Cegli, R. D., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2022.111601 · Cited by 28
ER stress‐induced autophagy in melanoma
Meng, X., Mu, Y., Zhang, X. D., Xu, H., & Dong, Q. (2015) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12436 · Cited by 28
Marcucci, F., & Rumio, C. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00714 · Cited by 28
T-Type Calcium Channels: A Potential Novel Target in Melanoma
Barceló, C., Sisó, P., Maiques, Ó., de la Rosa, I., Martí, R. M., & Macià, A. (2020) · Cancers · doi:10.3390/cancers12020391 · Cited by 28
Ghaznavi, H., Shirvaliloo, M., Zarebkohan, A., Shams, Z., Radnia, F., Bahmanpour, Z., Sargazi, S., Saravani, R., Shirvalilou, S., Shahraki, O., et al. (2021) · Molecular Pharmacology · doi:10.1124/molpharm.121.000234 · Cited by 28
Sannino, S., Yates, M. E., Schurdak, M. E., Oesterreich, S., Lee, A. V., Wipf, P., & Brodsky, J. L. (2021) · eLife · doi:10.7554/elife.64977 · Cited by 28
Grzywa, T. M., Klicka, K., Paskal, W., Dudkiewicz-Garbicz, J., Wejman, J., Pyźlak, M., & Wlodarski, P. K. (2020) · PLoS ONE · doi:10.1371/journal.pone.0234707 · Cited by 27
BRAF/MEK inhibition in NSCLC: mechanisms of resistance and how to overcome it
Tsamis, I., Gomatou, G., Chachali, S.-P., Trontzas, I. P., Patriarcheas, V., Panagiotou, Ε., & Kotteas, E. A. (2022) · Clinical & Translational Oncology · doi:10.1007/s12094-022-02849-0 · Cited by 27
Role of ROS‑mediated autophagy in melanoma (Review)
Zhang, X., Li, H., Liu, C., & Yuan, X. (2022) · Molecular Medicine Reports · doi:10.3892/mmr.2022.12819 · Cited by 27
Development of Novel Immunotherapies for Multiple Myeloma
Al-Hujaily, E. M., Oldham, R. A. A., Hari, P., & Medin, J. A. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17091506 · Cited by 27
White, K. A., Luo, L., Thompson, T. A., Torres, S. M., Hu, C. A., Thomas, N. E., Lilyquist, J., Anton‐Culver, H., Gruber, S. B., From, L., et al. (2016) · Cancer Medicine · doi:10.1002/cam4.929 · Cited by 27
Bustos, S. O., Pereira, G. J. S., Saito, R. D. F., Gil, C. D., Zanatta, D. B., Smaili, S. S., & Chammas, R. J. (2018) · Oncotarget · doi:10.18632/oncotarget.24516 · Cited by 27
Tang, J., Chen, Q., Xiang, L., Tu, T., Zhang, Y., & Ou, C. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04133-4 · Cited by 26
Xue, G., Kohler, R. S., Tang, F., Hynx, D., Wang, Y., Orso, F., Prêtre, V., Ritschard, R., Hirschmann, P., Cron, P. D., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.18213 · Cited by 26
Targeting autophagy in thyroid cancers
Wei, W., Hardin, H. A., & Luo, Q. (2019) · Endocrine Related Cancer · doi:10.1530/erc-18-0502 · Cited by 26
A Novel Polyamine-Targeted Therapy for BRAF Mutant Melanoma Tumors
Peters, M. C., Minton, A. R., Phanstiel, O., & Gilmour, S. K. (2018) · Medical Sciences · doi:10.3390/medsci6010003 · Cited by 26
He, J., Liu, L.-Y. D., Tang, F., Zhou, Y. L., Liu, H., Lu, C., Feng, D., Zhu, H., Mao, Y., Li, Z., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00787-x · Cited by 25
Metabolic rewiring directs melanoma immunology
Sun, N., Tian, Y., Chen, Y., Guo, W., & Li, C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.909580 · Cited by 25
Autophagy Paradox: Strategizing Treatment Modality in Melanoma
Pangilinan, C. R., Xu, X., Herlyn, M., & Liang, C. (2023) · Current Treatment Options in Oncology · doi:10.1007/s11864-023-01053-8 · Cited by 25
Self-citationAutophagy inhibition improves the cytotoxic effects of receptor tyrosine kinase inhibitors
Aveic, S., Pantile, M., Polo, P., Sidarovich, V., Mariano, M. D., Quattrone, A., Longo, L., & Tonini, G. P. (2018) · Cancer Cell International · doi:10.1186/s12935-018-0557-4 · Cited by 25
Rubinstein, J. C., Domanskyi, S., Sheridan, T., Sanderson, B. J., Park, S., Kaster, J., Li, H., Anczuków, O., Herlyn, M., & Chuang, J. H. (2024) · Cancer Research · doi:10.1158/0008-5472.can-24-0690 · Cited by 24
Self-citationYu, X., Li, W., Sun, S., & Li, J. (2025) · International Journal of Medical Sciences · doi:10.7150/ijms.120874 · Cited by 25
Yeramian, A., Vea, A. M., Benítez, S., Ribera, J., Domingo, M., Santacana, M., Martinez, M., Maiques, Ó., Valls, J., Dolcet, X., et al. (2016) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12472 · Cited by 24
PERK mediates resistance to BRAF inhibition in melanoma with impaired PTEN
Qin, Y., Zuo, Q., Huang, L., Huang, L., Merlino, G. T., & Yu, Y. (2021) · npj Precision Oncology · doi:10.1038/s41698-021-00207-x · Cited by 24
Zhang, Q., Huang, Z., Rui, X., Wang, Y., Wang, Y., Zhou, Y., Chen, R., Chen, Y., Wang, Y., Li, S., et al. (2022) · Cell Death Discovery · doi:10.1038/s41420-022-00915-8 · Cited by 24
Raghavendra, A. S., Kettner, N. M., Kwiatkowski, D. N., Damodaran, S., Wang, Y., Ramirez, D. L., Gombos, D. S., Hunt, K. K., Shen, Y., Keyomarsi, K., et al. (2025) · npj Breast Cancer · doi:10.1038/s41523-025-00722-1 · Cited by 24
Morais, K. L. P., Pacheco, M. T. F., Berra, C. M., Bösch, R. V., Sciani, J. M., Chammas, R. J., Saito, R. D. F., Iqbal, A., & Chudzinski‐Tavassi, A. M. (2016) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-016-2683-4 · Cited by 24
Garg, B., Pathria, G., Wagner, C., Maurer‐Granofszky, M., & Wagner, S. N. (2016) · Mutagenesis · doi:10.1093/mutage/gew023 · Cited by 24
Taguchi, Y., Horiuchi, Y., Kano, F., & Murata, M. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.147 · Cited by 24
Compensatory increases of select proteostasis networks after Hsp70 inhibition in cancer cells
Sannino, S., Guerriero, C. J., Sabnis, A. J., Stolz, D. B., Wallace, C. T., Wipf, P., Watkins, S. C., Bivona, T. G., & Brodsky, J. L. (2018) · Journal of Cell Science · doi:10.1242/jcs.217760 · Cited by 24
Han, Y., Fang, J., Xiao, Z., Deng, J. M., Zhang, M., & Gu, L. (2021) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-020-03484-4 · Cited by 24
Targeting UPR branches, a potential strategy for enhancing efficacy of cancer chemotherapy
Yu, M., Lun, J., Zhang, H., Wang, L., Zhang, G., Zhang, H., & Fang, J. S. (2021) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmab131 · Cited by 24
Self-citationXiang, Z., Hou, G., Zheng, S., Lu, M., Li, T., Lin, Q., Liu, H., Wang, X., Guan, T., Wei, Y., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2403038121 · Cited by 23
Rechallenge of targeted therapy in metastatic melanoma
Reschke, R., Simon, J., & Ziemer, M. (2019) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/ddg.13766 · Cited by 23
Secretory Autophagy Forges a Therapy Resistant Microenvironment in Melanoma
Bustos, S. O., Santos, N. L., Chammas, R. J., & Andrade, L. N. D. S. (2022) · Cancers · doi:10.3390/cancers14010234 · Cited by 23
Novel hypoxia-induced HIF-1αactivation in asthma pathogenesis
Wan, M., Yu, Q., Xu, F., You, L. X., Liang, X., Ren, K., & Zhou, J. (2024) · Respiratory Research · doi:10.1186/s12931-024-02869-0 · Cited by 23
Grazia, G., Vegetti, C., Benigni, F., Penna, I., Perotti, V., Tassi, E., Bersani, I., Nicolini, G., Canevari, S., Carlo‐Stella, C., et al. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.410 · Cited by 23
T‐type calcium channels drive migration/invasion in BRAFV 600E melanoma cells through Snail1
Maiques, Ó., Barceló, C., Panosa, A., Pijuan, J., Orgaz, J. L., Rodríguez‐Hernández, I., Matas‐Nadal, C., Tell‐Martí, G., Vilella, R., Fabra, À., et al. (2018) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12690 · Cited by 23
Mielczarek-Lewandowska, A., Sztiller-Sikorska, M., Osrodek, M., Czyż, M., & Hartman, M. L. (2019) · APOPTOSIS · doi:10.1007/s10495-019-01542-y · Cited by 23
V600EBRAF Inhibition Induces Cytoprotective Autophagy through AMPK in Thyroid Cancer Cells
Jiménez‐Mora, E., Tamayo, B. G., Gago, S. D., Lasa, M., Baquero, P., & Chiloeches, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22116033 · Cited by 23
Clinical Translation of Combined MAPK and Autophagy Inhibition in RAS Mutant Cancer
Lee, J. J., Jain, V., & Amaravadi, R. K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212402 · Cited by 23
Self-citationThe Identification and Development of a Novel Oncolytic Virus: Alphavirus M1
Cai, J., & Yan, G. (2020) · Human Gene Therapy · doi:10.1089/hum.2020.271 · Cited by 23
Yang, Y., Wang, S., Wang, X.-X., Guo, S., Wang, H., Shi, Q., Tian, Y., Wang, H., Zhao, T., Zhang, H., et al. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01470-8 · Cited by 22
Endoplasmic Reticulum Stress and Its Role in Metabolic Reprogramming of Cancer
Zarrella, S., Miranda, M. R., Covelli, V., Restivo, I., Novi, S., Pepe, G., Tesoriere, L., Rodriquez, M., Bertamino, A., Campiglia, P., et al. (2025) · Metabolites · doi:10.3390/metabo15040221 · Cited by 22
Wang, G., Zhou, Z., Jin, W., Zhang, X., Zhang, H., & Wang, X. (2023) · npj Precision Oncology · doi:10.1038/s41698-023-00483-9 · Cited by 22
Khalil, H., ElHady, A. A., Elawdan, K. A., Mohamed, D. D., Mohamed, D. D., Maksoud, A. I. A. E., El-Chennawi, F. A., El-Fikiy, B., & El-Sayed, I. H. (2020) · Immunological Investigations · doi:10.1080/08820139.2020.1828453 · Cited by 22
Autophagy, molecular chaperones, and unfolded protein response as promoters of tumor recurrence
Alhasan, B. A., Mikeladze, M. A., Guzhova, I. V., & Margulis, B. A. (2023) · Cancer and Metastasis Reviews · doi:10.1007/s10555-023-10085-3 · Cited by 22
Expression and release of glucose-regulated protein-78 (GRP78) in multiple myeloma
Steiner, N., Borjan, B., Hájek, R., Jöhrer, K., Göbel, G., Willenbacher, W., Kern, J., Gunsilius, E., & Untergasser, G. (2017) · Oncotarget · doi:10.18632/oncotarget.17353 · Cited by 22
Deficiency of the IRE1α-Autophagy Axis Enhances the Antitumor Effects of the Oncolytic Virus M1
Li, K., Hu, C., Xing, F., Gao, M., Liang, J., Xiao, X., Cai, J., Tan, Y., Hu, J. X., Zhu, W., et al. (2017) · Journal of Virology · doi:10.1128/jvi.01331-17 · Cited by 22
Self-citationLin, H., Chang, Y., Chen, R.-Y., Hung, L., Chen, P. C.-H., Chen, Y., Medeiros, L. J., Chiang, P., & Chang, K. (2021) · Cancer Science · doi:10.1111/cas.14833 · Cited by 21
NRF-mediated autophagy and UPR: Exploring new avenues to overcome cancer chemo-resistance
Dastghaib, S., Shafiee, S. M., Ramezani, F., Ashtari, N., Tabasi, F., Saffari‐Chaleshtori, J., Siri, M., Vakili, O., Igder, S., Zamani, M., et al. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.177210 · Cited by 20
Zhang, R., Zhu, Q., Yin, D., Yang, Z., Guo, J., Zhang, J., Zhou, Y., & Yu, J. J. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.597569 · Cited by 20
Awada, G., Schwarze, J. K., Tijtgat, J., Fasolino, G., Kruse, V., & Neyns, B. (2022) · Melanoma Research · doi:10.1097/cmr.0000000000000821 · Cited by 20
Characteristics and molecular mechanism of drug-tolerant cells in cancer: a review
Liang, X.-W., Liu, B., Chen, J.-C., Cao, Z. W., Chu, F.-R., Xiong, L., Wang, S.-Z., & Wu, J. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1177466 · Cited by 20
Liu, X., Chen, B., Liu, X., Zhang, X., & Wu, J. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1625357 · Cited by 19
Multiple Gastrointestinal Polyps in Patients Treated with BRAF Inhibitors
Amaravadi, R. K., Hamilton, K. E., Ma, X., Piao, S., Portillo, A. D., Nathanson, K. L., Carlino, M. S., Long, G. V., Puzanov, I. J., Xu, X., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-0469 · Cited by 19
Self-citationRoller, D. G., Capaldo, B. J., Bekiranov, S., Mackey, A. J., Conaway, M. R., Petricoin, E. F., Gioeli, D. G., & Weber, M. J. (2015) · Oncotarget · doi:10.18632/oncotarget.6548 · Cited by 19
Crosstalk between endoplasmic reticulum stress and multidrug-resistant cancers: hope or frustration
Qing, B., Wang, S., Du, Y., Liu, C., & Li, W. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1273987 · Cited by 19
Giglio, P., Fimia, G. M., Lovat, P. E., Piacentini, M., & Corazzari, M. (2015) · Molecular & Cellular Oncology · doi:10.4161/23723556.2014.995016 · Cited by 19
Ryabaya, O. O., Prokofieva, A. A., Khochenkov, D. A., Abramov, I. S., Zasedatelev, A. S., & Степанова, Е. В. (2018) · Oncology Reports · doi:10.3892/or.2018.6430 · Cited by 19
Baquero, P., Dawson, A., & Helgason, G. V. (2018) · FEBS Journal · doi:10.1111/febs.14659 · Cited by 19
Autophagy in BRAF-mutant cutaneous melanoma: recent advances and therapeutic perspective
Fratta, E., Giurato, G., Guerrieri, R., Colizzi, F., Col, J. D., Weisz, A., Steffan, A., & Montico, B. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01496-w · Cited by 18
RAF and MEK Inhibitors in Non-Small Cell Lung Cancer
Adamopoulos, C., Papavassiliou, K. A., Poulikakos, P. I., & Papavassiliou, A. G. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25094633 · Cited by 18
BRAF inhibitor resistance enhances vulnerability to arginine deprivation in melanoma
Li, Y.-Y., Wu, C., Chen, S.-M., Shah, S. S., Wangpaichitr, M., Feun, L. G., Kuo, M. T., Suarez, M., Prince, J. S., & Savaraj, N. (2016) · Oncotarget · doi:10.18632/oncotarget.6882 · Cited by 18
Degan, S., May, B. L., Jin, Y. J., Hammouda, M. B., Sun, H., Zhang, G., Wang, Y., Erdmann, D., Warren, W. S., & Zhang, J. Y. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.782877 · Cited by 18
Self-citationWang, Y., Wu, H., Li, Z., Yang, P., & Li, Z. (2016) · Experimental Cell Research · doi:10.1016/j.yexcr.2016.12.017 · Cited by 18
Novel organometallic chloroquine derivative inhibits tumor growth
Hall, E., Ramsey, J. E., Peng, Z., Hayrapetyan, D., Shkepu, V. I., O’Rourke, B., GEIGER, W. E. J., Lam, K., & Verschraegen, C. F. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26787 · Cited by 18
Induction of Endoplasmic Reticulum Stress as a Strategy for Melanoma Therapy: is there a Future?
Hill, D. S., Lovat, P. E., & Haass, N. K. (2014) · Melanoma Management · doi:10.2217/mmt.14.16 · Cited by 18
Advances in the Study of CircRNAs in Tumor Drug Resistance
Wang, S., Qian, L., Cao, T., Xu, L., Jin, Y., Hu, H., Fu, Q., Li, Q., Wang, Y., Wang, J., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.868363 · Cited by 17
Development of Personalized Strategies for Precisely Battling Malignant Melanoma
Isaak, A. J., Clements, G. R., Buenaventura, R. G. M., Merlino, G. T., & Yu, Y. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25095023 · Cited by 17
p20BAP31 Induces Autophagy in Colorectal Cancer Cells by Promoting PERK-Mediated ER Stress
Jiang, X., Li, G., Zhu, B., Yang, J., Cui, S., Jiang, R., & Wang, B. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25105101 · Cited by 17
Tumors Responsive to Autophagy-Inhibition: Identification and Biomarkers
Barbeau, L. M. O., Keulers, T. G., & Rouschop, K. M. A. (2020) · Cancers · doi:10.3390/cancers12092463 · Cited by 17
Mechanism of melanoma cells selective apoptosis induced by a photoactive NADPH analogue
Rouaud, F., Boucher, J., Slama‐Schwok, A., & Rocchi, S. (2016) · Oncotarget · doi:10.18632/oncotarget.12651 · Cited by 17
Cao, D.-S., Jiang, S.-L., Guan, Y.-D., Chen, X.-S., Zhang, L.-X., Zhang, Y., Chen, A. F., Yang, J.-M., & Cheng, Y. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112421 · Cited by 16
Gu, R., Fang, H., Wang, R., Dai, W., & Cai, G. (2024) · Clinical and Translational Medicine · doi:10.1002/ctm2.1764 · Cited by 17
Harnessing the polyamine transport system to treat BRAF inhibitor-resistant melanoma
Alexander, E. T., Naggar, O. S. E., Fahey, E., Mariner, K., Donnelly, J., Wolfgang, K., Phanstiel, O., & Gilmour, S. K. (2021) · Cancer Biology & Therapy · doi:10.1080/15384047.2021.1883185 · Cited by 16
Alam, R., Kabir, M. F., Kim, H., & Chae, H. (2022) · Cells · doi:10.3390/cells11233773 · Cited by 16
Jandová, J., Park, S., Corenblum, M. J., Madhavan, L., Snell, J. A., Rounds, L., & Wondrak, G. T. (2022) · Molecular Carcinogenesis · doi:10.1002/mc.23407 · Cited by 16
Zhang, J., Tang, Z., Xi, G., Wang, Y., Zhou, Y., & Cai, W. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.933646 · Cited by 16
Plant, A., & Tabori, U. Y. (2024) · Child s Nervous System · doi:10.1007/s00381-024-06504-7 · Cited by 15
The Lysosome in Malignant Melanoma: Biology, Function and Therapeutic Applications
Hsu, C., Lee, K., Chiu, Y., Huang, K.-C., Wang, G., Chen, L.-P., Liao, K., & Lin, C. (2022) · Cells · doi:10.3390/cells11091492 · Cited by 15
Metadata
- Authors
- Ma, X.-H., Piao, S.-F., Dey, S., Mcafee, Q., Karakousis, G., Villanueva, J., Hart, L. S., Levi, S., Hu, J., Zhang, G., Lazova, R., Klump, V., Pawelek, J. M., Xu, X., Xu, W., Schuchter, L. M., Davies, M. A., Herlyn, M., Winkler, J., Koumenis, C., & Amaravadi, R. K.
- Affiliations
- University of Pennsylvania (US)
- The Wistar Institute (US)
- Yale University (US)
- Abramson Cancer Center (US)
- The University of Texas MD Anderson Cancer Center (US)
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2014-02-24
- Volume
- 124
- Issue
- 3
- Pages
- 1406-1417
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC3934165
- OpenAlex
- W2119735934
- Cited by
- 457
- References
- 52
- Citations by year
- 2026: 11 · 2025: 36 · 2024: 39 · 2023: 27 · 2022: 37 · 2021: 40 · 2020: 40 · 2019: 35 · 2018: 44 · 2017: 44 · 2016: 48 · 2015: 31 · 2014: 24
- FWCI
- 20.08
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Pennsylvania
- National Institutes of Health
- National Cancer Institute (P01CA114046, R01CA139362, K01CA175269, K23CA120862, R01CA169134, R01CA094214, P30CA016672, P30CA010815, P30CA016520)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Endoplasmic Reticulum Stress and Disease
- Keywords
- melanoma, BRAF inhibitor resistance, BRAF V600E mutation, endoplasmic reticulum stress, autophagy, cytoprotective autophagy, GRP78, PERK, MEK inhibition, autophagy inhibition, combination therapy, PI3K/mTOR signaling, progression-free survival
- MeSH terms
- Vemurafenib, Endoplasmic Reticulum Chaperone BiP, Animals, Antineoplastic Agents, Autophagy, Humans, Indoles, Melanoma, Mice, Nude, Sulfonamides, Drug Resistance, Neoplasm, Mutation, Missense, MAP Kinase Signaling System, Xenograft Model Antitumor Assays, Cell Line, Tumor, Proto-Oncogene Proteins B-raf, Cell Proliferation, Mice, Endoplasmic Reticulum Stress
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.